can tirzepatide cause pancreatic cancer and semaglutide pancreatic cancer Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management New study on pancreatic cancer

Obesity is linked to a wide range of comorbidities, including type 2 diabetes, cardiovascular diseases, and cancer, contributing to increased morbidity and mortality

REFERENCE Study Reference: Randomized controlled trial of oral glutathione supplementation on body stores of glutathione (published in European Journal of Nutrition) investigated the effects of daily oral glutathione (GSH) at 250 mg and 1,000 mg per day for six months

Watch the video below to uncover the secret

And thanks to Thiemo for the question

Prescription weight loss medications, known for their ability to aid in long-term weight management, can play a crucial role